## **Core Concept**
Acute Lymphoblastic Leukemia (ALL) is a type of cancer that affects the blood and bone marrow, characterized by the overproduction of immature white blood cells, known as lymphoblasts. The prognosis of ALL depends on various factors, including age, white blood cell count at diagnosis, presence of specific genetic abnormalities, and response to initial treatment.

## **Why the Correct Answer is Right**
The correct answer, , indicates that a high white blood cell count (WBC) at diagnosis is a poor prognostic factor in ALL. This is because a high WBC count is often associated with a greater tumor burden and a higher risk of central nervous system (CNS) involvement. Patients with high WBC counts at diagnosis tend to have a lower likelihood of achieving complete remission and a higher risk of relapse.

## **Why Each Wrong Option is Incorrect**
* **Option A:** is incorrect because a low age ( 10 years) is generally considered a poor prognostic factor, but the specific age range can vary. However, being younger (especially under 10) generally has a better prognosis.
* **Option B:** is incorrect because the presence of the Philadelphia chromosome (t(9;22)) is indeed a poor prognostic factor, but it's not listed; however, other genetic markers like MLL gene rearrangement in infants are poor prognostic indicators.
* **Option C:** is incorrect because certain genetic abnormalities, such as the presence of the TEL-AML1 fusion gene (t(12;21)), are actually associated with a favorable prognosis in ALL.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl in ALL is that early response to treatment, as evidenced by minimal residual disease (MRD) status after induction chemotherapy, is a powerful predictor of long-term outcome. Patients with MRD negativity tend to have a better prognosis than those with persistent MRD positivity.

## **Correct Answer:** . High WBC count at diagnosis.